Notice of NIAAA's Participation in PAR-11-169 "Clinical Trial Planning Cooperative Agreement (U34)"

Notice Number: NOT-AA-13-004

Key Dates
Release Date: July 12, 2013

Related Announcements
PAR-11-169

Issued by
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Purpose

The purpose of this Notice is to inform potential applicants of the National Institute on Alcohol Abuse and Alcoholism’s (NIAAA’s) participation, effective immediately, in the Funding Opportunity Announcement (FOA) PAR-11-169  entitled "Clinical Trial Planning Cooperative Agreement (U34)"
The following sections of PAR-11-169  have been updated to reflect the participation of NIAAA in this FOA:

Part 1. Overview Information
Components of Participating Organizations
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.846, 93.273

Part 2. Section I. Funding Opportunity Description
For this FOA, NIAAA's interest includes:

This FOA issued invites applications to obtain critical and necessary support in the planning and development of feasible and well-designed multicenter clinical trials focused on the effects of moderate consumption of alcohol (as defined by NIAAA guidelines) on the decreased or increased risk of certain chronic diseases. This FOA is designed to support planning activities in preparation for a full-scale Phase III multicenter clinical trial, which will require subsequent application via a UM1 or a U10 mechanism. Prospective applicants should however note that funding of a Clinical Trial Planning Grant does not guarantee or imply funding for a subsequent application..

Part 2. Section IV. Application and Submission Information
The Letter of Intent for applications requesting funding from NIAAA should be emailed to:

Abraham P. Bautista, Ph.D.
Director, Office of Extramural Activities
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institutes of Health
5635 Fishers Lane, Room 2003
Rockville MD 20852
Email: bautista@mail.nih.gov

Part 2. Section V. Application Review Information
2. Review and Selection Process
Applications assigned to the NIAAA will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s) convened by the NIAAA.  Following initial peer review, recommended applications will receive a second level of review by the NIAAA Advisory Council.

Part 2. Section VII. Agency Contacts
Scientific/Research Contact(s)
Lorraine Gunzerath, Ph.D., M.B.A.
Senior Advisor to the Director
Office of the Director
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-402-0332
Email: lg72x@nih.gov

Peer Review Contact(s)
Ranga Srinivas, Ph.D.
Chief, Extramural Project Review Branch
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-451-2067
Email: ranga.srinivas@nih.gov

Financial/Grants Management Contact(s)
Judy Fox
Chief, Grants Management Branch
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-4704
Email: Judy.Fox@nih.gov

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Lorraine Gunzerath, Ph.D., M.B.A.
Senior Advisor to the Director
Office of the Director
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-402-0332
Email: lg72x@nih.gov

 


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices



NIH Office of Extramural Research Logo
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®



Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.